Posted by ABMN Staff on Mar 29th, 2024
bluebird bio, Inc. (NASDAQ:BLUE – Free Report) – Leerink Partnrs cut their Q1 2024 earnings estimates for bluebird bio in a research report issued on Tuesday, March 26th. Leerink Partnrs analyst M. Foroohar now anticipates...
More of this article »